Cytomegalovirus Control in Critical Care

NCT01503918 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Critical Illness

Interventions

DRUG: Valaciclovir/Aciclovir
DRUG: Valganciclovir/Ganciclovir

Sponsor

University Hospital Birmingham NHS Foundation Trust

Collaborators

[object Object]